A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers
[post]
2020
unpublished
Background: This study aims to develop and validate a novel prognostic model to estimate overall survival (OS) in nasopharyngeal carcinoma (NPC) patients based on clinical features and blood biomarkers. We assessed the model's incremental value to the TNM staging system, clinical treatment, and Epstein-Barr virus (EBV) DNA copy number for individual OS estimation. Methods: We retrospectively analyzed 519 consecutive patients with NPC. A prognostic model was generated using the Lasso regression
doi:10.21203/rs.3.rs-54154/v2
fatcat:usziaonhevb3xci2rabzqspr7e